FDA funding future brightens

The Senate Appropriations Committee approved a whopping budget of more than two billion dollars for the FDA in 2009. On Thursday (July 17), the committee unanimously passed the markup, which would represent an increase of more than $324 million over the FDA's 2008 budget and the first time the agency's budget would breech the two billion dollar mark. The FDA budget boost is part of a larger bill, totaling almost $20.5 billion, that also contains provisions for global food assistance, rental ass

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The Senate Appropriations Committee approved a whopping budget of more than two billion dollars for the FDA in 2009. On Thursday (July 17), the committee unanimously passed the markup, which would represent an increase of more than $324 million over the FDA's 2008 budget and the first time the agency's budget would breech the two billion dollar mark. The FDA budget boost is part of a larger bill, totaling almost $20.5 billion, that also contains provisions for global food assistance, rental assistance for some low-income households, and rural development. President George Bush has threatened to veto the bill, as it outspends his linkurl:FY 2009 budget request.;http://www.the-scientist.com/blog/display/54277/ "I call on President to reconsider his unwise veto threats," said Appropriations Committee chair Senator Robert Byrd (D-WV) during the session. "Now is not the time to cut or eliminate programs that invest in the growth of our nation." The measure now moves on to the Senate floor. A companion measure is making its way through committee in the linkurl:House.;http://www.the-scientist.com/blog/display/54774/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo